drugset / Trial / NCT06877624
A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to evaluate the pharmacokinetics of three QRL-101 formulations in a fasted condition or in the presence of a high-fat meal in healthy participants.
Timeline
- Start
- 2025-01-10
- Primary completion
- 2025-05-15
- Completion
- 2025-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QRL-101 | Unknown | — | — |
Indications
No indication recorded.